151 related articles for article (PubMed ID: 8370839)
1. MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy.
Hill SC; Parker CC; Brady RO; Barton NW
J Comput Assist Tomogr; 1993; 17(5):806-9. PubMed ID: 8370839
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
3. Metaphyseal undertubulation in gaucher disease: resolution at MRI in a patient undergoing enzyme replacement therapy.
Kelman CG; Disler DG
J Comput Assist Tomogr; 2000; 24(1):173-5. PubMed ID: 10667678
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow relaxation times in Gaucher disease before and after enzyme replacement therapy.
Magnaldi S; Longo R; Ukmar M; Zanatta M; Bottega M; Sottocasa GL
Eur Radiol; 1997; 7(4):486-91. PubMed ID: 9204325
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ
J Pediatr; 2004 Jan; 144(1):112-20. PubMed ID: 14722528
[No Abstract] [Full Text] [Related]
7. Retrospective Analysis of Whole-Body Magnetic Resonance Imaging of Bone Manifestations in Long-Term Treated Patients with Gaucher Disease Type 1.
Lollert A; Laudemann K; Mengel E; Hoffmann C; Moos L; Reinke J; Brixius-Huth M; Hennermann JB; Düber C; Staatz G
Klin Padiatr; 2019 Mar; 231(2):52-59. PubMed ID: 30481833
[TBL] [Abstract][Full Text] [Related]
8. Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher.
vom Dahl S; Poll LW; Häussinger D
Br J Haematol; 2001 Jun; 113(4):1084-7. PubMed ID: 11442513
[No Abstract] [Full Text] [Related]
9. Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease.
Tanaka N; Saito H; Ito T; Momose K; Ishida F; Hora K; Kiyosawa K; Ida H
Intern Med; 2001 Aug; 40(8):716-21. PubMed ID: 11518109
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
[TBL] [Abstract][Full Text] [Related]
11. Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb.
Aoki M; Takahashi Y; Miwa Y; Iida S; Sukegawa K; Horai T; Orii T; Kondo N
Eur J Pediatr; 2001 Jan; 160(1):63-4. PubMed ID: 11195024
[TBL] [Abstract][Full Text] [Related]
12. Bone complications in children with Gaucher disease.
Bembi B; Ciana G; Mengel E; Terk MR; Martini C; Wenstrup RJ
Br J Radiol; 2002; 75 Suppl 1():A37-44. PubMed ID: 12036831
[TBL] [Abstract][Full Text] [Related]
13. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
Robertson PL; Maas M; Goldblatt J
AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
Poll LW; Koch JA; vom Dahl S; Willers R; Scherer A; Boerner D; Niederau C; Häussinger D; Mödder U
Skeletal Radiol; 2001 Sep; 30(9):496-503. PubMed ID: 11587517
[TBL] [Abstract][Full Text] [Related]
15. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
16. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement.
Hermann G; Pastores GM; Abdelwahab IF; Lorberboym AM
Skeletal Radiol; 1997 Dec; 26(12):687-96. PubMed ID: 9453101
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy in type III Gaucher disease.
Tylki-Szymańska A; Czartoryska B
J Inherit Metab Dis; 1999 Apr; 22(2):203-4. PubMed ID: 10234625
[No Abstract] [Full Text] [Related]
18. Interruption in enzyme replacement therapy for Gaucher disease.
Weinreb NJ
Br J Haematol; 2001 Jun; 113(4):1087-9. PubMed ID: 11442515
[No Abstract] [Full Text] [Related]
19. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
20. Large soft-tissue masses in an adult patient with Gaucher disease.
Mahajan N; Brynes R; Yano S
J Inherit Metab Dis; 2016 Nov; 39(6):887-888. PubMed ID: 27503099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
